Life Technologies Corp (LIFE.O)
74.10USD
22 May 2013
$0.42 (+0.57%)
$73.68
$74.09
$74.33
$73.82
7,220,110
3,520,291
$74.33
$39.73
LIFE.O
About
Overall
| Beta: | 0.97 |
| Market Cap (Mil.): | $12,678.65 |
| Shares Outstanding (Mil.): | 172.08 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| LIFE.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 31.13 | 53.09 | 35.13 |
| EPS (TTM): | 2.37 | -- | -- |
| ROI: | 5.60 | 0.99 | 18.83 |
| ROE: | 8.93 | 1.98 | 19.68 |
Roche, Sigma teamed up for failed Life Technologies bid: sources
NEW YORK - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said.
Roche, Sigma teamed up for failed Life Technologies bid -sources
NEW YORK, May 21 - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said.
Thermo Fisher profit tops Street view as Life awaits
- Laboratory equipment maker Thermo Fisher Scientific Inc, which this month agreed to acquire Life Technologies Inc for more than $13 billion, on Wednesday reported a higher-than-expected first-quarter profit, helped by a 10 percent rise in specialty diagnostics sales.
Big U.S. corporate takeovers drive 'Merger Monday'
* Barclays No. 3 global M&A adviser, JPMorgan tops league table
Fitch Places Life Technologies' Ratings on Negative Watch
(The following statement was released by the rating agency) NEW YORK, April 15 (Fitch) Fitch Ratings has removed the ratings of Life Technologies Corp (Life Tech), including the 'BBB' Issuer Default Rating (IDR), from Rating Watch Evolving and placed them on Rating Watch Negative. The action follows Thermo Fisher Scientific Inc.'s (Thermo Fisher) announcement that it plans to acquire Life Tech. The ratings apply to approximately $2.2 billion of debt outstanding at Dec. 31, 2012. Key Rating
Thermo Fisher to buy Life Tech for $13.6 billion
NEW YORK - Thermo Fisher Scientific Inc on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would make it one of the top two companies in the hot field of genetic testing.
UPDATE 4-Thermo Fisher to buy Life Tech for $13.6 billion
* Thermo Fisher to pay $76 per share, a 12 percent premium
Fitch Places Thermo Fisher's Ratings on Negative Watch
(The following statement was released by the rating agency) NEW YORK, April 15 (Fitch) Fitch Ratings has placed Thermo Fisher Scientific Inc.'s (Thermo Fisher) ratings, including the 'BBB+' Issuer Default Rating (IDR), on Rating Watch Negative. The action follows the company's announcement that it will acquire Life Technologies Corp. (Life Tech) for a total consideration of about $15.8 billion. The ratings apply to $7.1 billion of debt outstanding at Dec. 31, 2012. A full list of ratings fo
BRIEF-Thermo Fisher Scientific shares up after buyout of Life Tech
NEW YORK, April 15 - Thermo Fisher Scientific Inc : * Shares up 1.3 percent in premarket trade after buyout of Life Tech
BRIEF-Life Technologies shares up after buyout by Thermo Fisher
NEW YORK, April 15 - Life Technologies Corp : * Shares resume trading; up 7.7 percent in premarket trade after buyout by
Competitors
| Price | Change | |
|---|---|---|
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $93.03 | +0.12 |
| Affymetrix, Inc. (AFFX.OQ) | $3.67 | -0.06 |
| Johnson & Johnson (JNJ.N) | $88.46 | -0.13 |
| Novartis AG (NOVN.VX) | CHF73.65 | +1.25 |
| Roche Holding Ltd. (ROG.VX) | CHF258.50 | +7.50 |
| Merck & Co., Inc. (MRK.N) | $46.71 | -0.62 |
| Sanofi SA (SASY.PA) | €86.43 | +1.29 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
